M. Hirakata

1.2k total citations
42 papers, 888 citations indexed

About

M. Hirakata is a scholar working on Epidemiology, Pathology and Forensic Medicine and Rheumatology. According to data from OpenAlex, M. Hirakata has authored 42 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 11 papers in Pathology and Forensic Medicine and 11 papers in Rheumatology. Recurrent topics in M. Hirakata's work include Inflammatory Myopathies and Dermatomyositis (16 papers), Systemic Sclerosis and Related Diseases (9 papers) and Systemic Lupus Erythematosus Research (7 papers). M. Hirakata is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (16 papers), Systemic Sclerosis and Related Diseases (9 papers) and Systemic Lupus Erythematosus Research (7 papers). M. Hirakata collaborates with scholars based in Japan, United States and Australia. M. Hirakata's co-authors include Akira Suwa, John Hardin, Tatsuyuki Mimori, Yoshihiko Takeda, Stephen A. Jesch, Hideto Kameda, M Akizuki, Yutaka Okano, Masataka Kuwana and Tsuneyo Mimori and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

M. Hirakata

39 papers receiving 865 citations

Peers

M. Hirakata
Eva Balada Spain
Margarita Rodríguez‐Mahou Spain
Christoph Deuter Germany
Maria P. Karampetsou Switzerland
Ji-Yih Chen Taiwan
P. A. Dyer United Kingdom
Ziyan Wu China
Yasuo Ohosone Japan
I. Koetter Germany
W E Ollier United Kingdom
Eva Balada Spain
M. Hirakata
Citations per year, relative to M. Hirakata M. Hirakata (= 1×) peers Eva Balada

Countries citing papers authored by M. Hirakata

Since Specialization
Citations

This map shows the geographic impact of M. Hirakata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Hirakata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Hirakata more than expected).

Fields of papers citing papers by M. Hirakata

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Hirakata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Hirakata. The network helps show where M. Hirakata may publish in the future.

Co-authorship network of co-authors of M. Hirakata

This figure shows the co-authorship network connecting the top 25 collaborators of M. Hirakata. A scholar is included among the top collaborators of M. Hirakata based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Hirakata. M. Hirakata is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hanaoka, Hironari, Yuko Kaneko, Shigeaki Suzuki, et al.. (2015). Anti-signal recognition particle antibody in patients without inflammatory myopathy: a survey of 6180 patients with connective tissue diseases. Scandinavian Journal of Rheumatology. 45(1). 36–40. 7 indexed citations
2.
3.
Shimane, Kenichi, Yuta Kochi, Akari Suzuki, et al.. (2013). An association analysis of HLA-DRB1 with systemic lupus erythematosus and rheumatoid arthritis in a Japanese population: effects of *09:01 allele on disease phenotypes. Lara D. Veeken. 52(7). 1172–1182. 56 indexed citations
4.
Takizawa, Yasunobu, Shigeko Inokuma, Yuji Tanaka, et al.. (2008). Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population. Lara D. Veeken. 47(9). 1373–1378. 99 indexed citations
5.
Suwa, Akira, M. Hirakata, Yuko Kaneko, et al.. (2008). Successful treatment of refractory polymyositis with the immunosuppressant mizoribine: case report. Clinical Rheumatology. 28(2). 227–229. 3 indexed citations
6.
Nakamura, Morihiko, Yoko Tanaka, Takashi Satoh, et al.. (2005). Autoantibody to CD40 ligand in systemic lupus erythematosus: association with thrombocytopenia but not thromboembolism. Lara D. Veeken. 45(2). 150–156. 25 indexed citations
7.
8.
Miyachi, Kiyomitsu, Yasuhiro Hirano, Tsuneyo Mimori, et al.. (2004). Autoantibodies from primary biliary cirrhosis patients with anti-p95c antibodies bind to recombinant p97/VCP and inhibitin vitronuclear envelope assembly. Clinical & Experimental Immunology. 136(3). 568–573. 22 indexed citations
9.
Hirakata, M.. (2000). Humoral aspects of polymyositis/dermatomyositis. Modern Rheumatology. 10(4). 199–206. 8 indexed citations
10.
Hirakata, M.. (2000). Humoral aspects of polymyositis/dermatomyositis. Modern Rheumatology. 10(4). 199–206. 2 indexed citations
11.
Suwa, Akira, et al.. (1998). Malignant melanoma in a patient with rheumatoid arthritis [2]. Clinical and Experimental Rheumatology. 16(4). 2 indexed citations
12.
Fujii, Takashi, M Akizuki, Hideto Kameda, et al.. (1997). Methotrexate treatment in patients with adult onset Still's disease—retrospective study of 13 Japanese cases. Annals of the Rheumatic Diseases. 56(2). 144–148. 61 indexed citations
13.
Ohosone, Yasuo, Yutaka Okano, Hideto Kameda, et al.. (1997). Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis.. PubMed. 24(12). 2299–303. 49 indexed citations
14.
Suwa, Akira, M. Hirakata, Yoshihiko Takeda, et al.. (1996). Autoantibodies to DNA-dependent protein kinase. Probes for the catalytic subunit.. Journal of Clinical Investigation. 97(6). 1417–1421. 30 indexed citations
15.
Satoh, Minoru, N Hama, M. Hirakata, et al.. (1995). MASSIVE PERICARDIAL EFFUSION IN SCLERODERMA: A REVIEW OF FIVE CASES. Lara D. Veeken. 34(6). 564–567. 25 indexed citations
16.
Satoh, Minoru, Ajay Ajmani, Takashi Ogasawara, et al.. (1994). Autoantibodies to RNA polymerase II are common in systemic lupus erythematosus and overlap syndrome. Specific recognition of the phosphorylated (IIO) form by a subset of human sera.. Journal of Clinical Investigation. 94(5). 1981–1989. 53 indexed citations
17.
Hirakata, M., Yutaka Okano, Uttam Pati, et al.. (1993). Identification of autoantibodies to RNA polymerase II. Occurrence in systemic sclerosis and association with autoantibodies to RNA polymerases I and III.. Journal of Clinical Investigation. 91(6). 2665–2672. 52 indexed citations
18.
Hirakata, M., J. Carl Craft, & John Hardin. (1993). Autoantigenic epitopes of the B and D polypeptides of the U1 snRNP. Analysis of domains recognized by the Y12 monoclonal anti-Sm antibody and by patient sera. The Journal of Immunology. 150(8). 3592–3601. 32 indexed citations
19.
Hirakata, M., M Akizuki, Yutaka Okano, et al.. (1988). Pyloric stenosis in a patient with progressive systemic sclerosis. Clinical Rheumatology. 7(3). 394–397. 4 indexed citations
20.
Hirakata, M., et al.. (1988). Coexistence of CREST syndrome and primary biliary cirrhosis. Serological studies of two cases.. PubMed. 15(7). 1166–70. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eva Balada Breakdown of academic impact, for papers by Margarita Rodríguez‐Mahou Breakdown of academic impact, for papers by Christoph Deuter Breakdown of academic impact, for papers by Maria P. Karampetsou Breakdown of academic impact, for papers by Ji-Yih Chen Breakdown of academic impact, for papers by P. A. Dyer Breakdown of academic impact, for papers by Ziyan Wu Breakdown of academic impact, for papers by Yasuo Ohosone Breakdown of academic impact, for papers by I. Koetter Breakdown of academic impact, for papers by W E Ollier
Rankless by CCL
2026